Evidence map›Paper›PMID 28481870›Full record

ArticleOncogene2017

Thrombospondin-4 mediates TGF-β-induced angiogenesis.

S Muppala, R Xiao, I Krukovets, D Verbovetsky, R Yendamuri, N Habib, P Raman, E Plow, O Stenina-Adognravi

Abstract read
In one paragraph

Article in Oncogene, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 80 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
80citing papers in PubMed, 1 pooled it
5.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

80 citing papers in PubMed, 1 synthesis or guideline pooled it, 169 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Signaling networks in cancer stromal senescent cells establish malignant microenvironment.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Observational
  20. Article

20 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

S MuppalaDepartment of Molecular Cardiology, Cleveland Clinic, Cleveland, OH, USA.
R XiaoDepartment of Molecular Cardiology, Cleveland Clinic, Cleveland, OH, USA.
I KrukovetsDepartment of Molecular Cardiology, Cleveland Clinic, Cleveland, OH, USA.
D VerbovetskyDepartment of Molecular Cardiology, Cleveland Clinic, Cleveland, OH, USA.
R YendamuriDepartment of Molecular Cardiology, Cleveland Clinic, Cleveland, OH, USA.
N HabibDepartment of Molecular Cardiology, Cleveland Clinic, Cleveland, OH, USA.
P RamanDepartment of Integrative Medical Sciences, North Ohio Medical University, Rootstown, OH, USA.
E PlowDepartment of Molecular Cardiology, Cleveland Clinic, Cleveland, OH, USA.
O Stenina-AdognraviDepartment of Molecular Cardiology, Cleveland Clinic, Cleveland, OH, USA.
Cleveland Clinic · USNortheast Ohio Medical University · US

Funding

Clinical and Translational Science Collaborative of ClevelandUL1TR000439 · NCATS · CASE WESTERN RESERVE UNIVERSITY · PI KONSTAN, MICHAEL W. · 2012 to 2016
$50.0M
TSP-4 genetic variants in atherogenesis and angiogenesisR01HL117216 · NHLBI · CLEVELAND CLINIC LERNER COM-CWRU · PI PLOW, EDWARD FRANKLIN, STENINA, OLGA I · 2013 to 2017
$1.9M
Tissue Specific Regulation of Diabetes-Associated Cancer GrowthR01CA177771 · NCI · CLEVELAND CLINIC LERNER COM-CWRU · PI STENINA, OLGA I · 2014 to 2018
$1.6M
NCATS NIH HHS UL1 TR000439NCI NIH HHS R01 CA177771NHLBI NIH HHS R01 HL117216
6 · The paper itself

Abstract

TGF-β is a multifunctional cytokine affecting many cell types and implicated in tissue remodeling processes. Due to its many functions and cell-specific effects, the consequences of TGF-β signaling are process-and stage-dependent, and it is not uncommon that TGF-β exerts distinct and sometimes opposing effects on a disease progression depending on the stage and on the pathological changes associated with the stage. The mechanisms underlying cell- and process-specific effects of TGF-β are poorly understood. We are describing a novel pathway that mediates induction of angiogenesis in response to TGF-β1. We found that in endothelial cells (EC) thrombospondin-4 (TSP-4), a secreted extracellular matrix (ECM) protein, is upregulated in response to TGF-β1 and mediates the effects of TGF-β1 on angiogenesis. Upregulation of TSP-4 does not require the synthesis of new protein, is not caused by decreased secretion of TSP-4, and is mediated by activation of SMAD3. Using Thbs4

Indexed as

Angiogenesis Inducing AgentsAnimalsCell MovementCell ProliferationCells, CulturedChick EmbryoEndothelium, VascularFemaleGene Expression RegulationHumansMaleMiceMice, Inbred C57BLMuscle, Smooth, VascularNeovascularization, PathologicSignal TransductionAngiogenesis Inducing Agentsthrombospondin 4ThrombospondinsTransforming Growth Factor beta

Identifiers

PMID28481870
PMCPMC5589494
OpenAlexW2613374109

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.